NURECA
Back to Cashflow Statement
|
NURECA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3.30 Cr | ₹-19 Cr | ₹-2.71 Cr | ₹10 Cr | ₹1.40 Cr |
What is the latest Cash Flow from Operating Activities ratio of NURECA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3.30 Cr |
| Mar2025 | ₹-19 Cr |
| Mar2024 | ₹-2.71 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹1.40 Cr |
How is Cash Flow from Operating Activities of NURECA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.30 Cr | Positive | |
| Mar2025 | ₹-19 Cr | Negative | |
| Mar2024 | ₹-2.71 Cr | Negative | |
| Mar2023 | ₹10 Cr | 631.02 | |
| Mar2022 | ₹1.40 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NURECA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NURECA | ₹331.1 Cr | -0.7% | 1.9% | 56.9% | Stock Analytics | |
| LENSKART SOLUTIONS | ₹120,264.0 Cr | 1.6% | 4.2% | NA | Stock Analytics | |
| POLY MEDICURE | ₹16,606.6 Cr | -5% | -6.7% | -17.6% | Stock Analytics | |
| 3B BLACKBIO DX | ₹1,420.3 Cr | 13.1% | 8.7% | 22.5% | Stock Analytics | |
| LAXMI DENTAL | ₹1,065.9 Cr | -3.1% | 0.9% | -40.5% | Stock Analytics | |
| PREVEST DENPRO | ₹452.6 Cr | -0.8% | -1.7% | -31.6% | Stock Analytics | |
NURECA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NURECA | -0.7% |
1.9% |
56.9% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses